⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3195301 | 1.00 | — | — | |
| SCHEMBL28127904 | 0.97 | — | — | |
| SCHEMBL16078732 | 0.80 | PTGS1 (0.32) | — | |
| SCHEMBL3423329 | 0.75 | MEN1 (0.32) | — | |
| N,N-Dimethylethanaminium SCHEMBL27584119 | 0.73 | PTGS1 (0.38) | — | |
| SCHEMBL17385623 | 0.73 | — | — | |
| SCHEMBL14572726 | 0.73 | — | — | |
| SCHEMBL10593599 | 0.73 | — | — | |
| SCHEMBL9704284 | 0.72 | CA5A (0.36) | — | |
| Trimethylammonium SCHEMBL10347845 | 0.72 | CA5A (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003028739-A2 | COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA OR HYPERGLYCEMIA COMPRISING A POLYMER OR ITS SALT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-04-10 | — | — | WO | disclosed |
| WO-2002032974-A2 | POLYMER AND ITS USE FOR THE TREATMENT AND/OR PREVENTION OF HYPERPHOSPHOREMIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-04-25 | — | — | WO | disclosed |